BIOLOGÍA CELULAR Y PATOLOGÍA
Departamento
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (10)
2023
-
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
Journal for immunotherapy of cancer, Vol. 11, Núm. 2
2019
-
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Blood, Vol. 133, Núm. 22, pp. 2401-2412
2016
-
Effect of mTORC1/mTORC2 inhibition on T cell function: Potential role in graft-versus-host disease control
British Journal of Haematology, Vol. 173, Núm. 5, pp. 754-768
-
Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development
Journal of Hematology and Oncology, Vol. 9, Núm. 1
2015
-
Human bone marrow stromal cells differentiate into corneal tissue and prevent ocular graft-versus-host disease in mice
Cell Transplantation, Vol. 24, Núm. 12, pp. 2423-2433
-
Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential
Leukemia, Vol. 29, Núm. 5, pp. 1186-1194
2014
-
Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations
Leukemia
-
Lineage-specific function of Engrailed-2 in the progression of chronic myelogenous leukemia to T cell blast crisis
Cell Cycle, Vol. 13, Núm. 11, pp. 1717-1726
-
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma
Nature Communications, Vol. 5
2013
-
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
Blood, Vol. 122, Núm. 22, pp. 3591-3598